In our study, we analyzed patient factors that might be associated with the clinical severity of CHI, including standard patient demographics and baseline characteristics, the presence of genetic mutations in the ABCC8/KCNJ11 genes, and the use of concomitant medications such as diazoxide and/or octreotide. Here, ABCC8 is linked to congenital isolated hyperinsulinism.